Latest Insider Transactions at Bone Biologics Corp (BBLG)
This section provides a real-time view of insider transactions for Bone Biologics Corp (BBLG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Bone Biologics Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Bone Biologics Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2023
|
Deina H Walsh Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
8,000
+34.78%
|
$0
$0.64 P/Share
|
|
Sep 11
2023
|
Jeff Frelick Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
9,500
+35.58%
|
$0
$0.69 P/Share
|
|
Sep 06
2023
|
Deina H Walsh Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
7,000
+49.45%
|
$0
$0.71 P/Share
|
|
Aug 31
2023
|
Jeff Frelick Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
7,600
+49.66%
|
$0
$0.66 P/Share
|
|
Mar 13
2023
|
Don Hankey Chairman of the Board |
SELL
Other acquisition or disposition
|
Indirect |
500,137
-100.0%
|
-
|
|
Oct 15
2021
|
Don Hankey Chairman of the Board |
SELL
Bona fide gift
|
Indirect |
1,004,310
-12.51%
|
-
|
|
Oct 15
2021
|
Don Hankey Chairman of the Board |
BUY
Discretionary transaction
|
Indirect |
476,190
+5.6%
|
$2,380,950
$5.24 P/Share
|
|
Oct 15
2021
|
Don Hankey Chairman of the Board |
SELL
Conversion of derivative security
|
Indirect |
9,361,702
-55.34%
|
-
|
|
Oct 15
2021
|
Don Hankey Chairman of the Board |
BUY
Conversion of derivative security
|
Indirect |
5,928,774
+25.95%
|
$11,857,548
$2.5 P/Share
|